For years, pharmaceutical companies across Europe and beyond have poured investment into their websites and social media channels, hoping to earn the attention and the trust of time-pressured healthcare professionals (HCPs). That investment is finally beginning to show measurable returns, with web and social among the very few channels to improve in the 2025 CXQ research. Yet just as the industry finds its footing, the ground is shifting again.
As AI-powered search and answer engines increasingly mediate how clinical information is discovered, the question facing pharma is no longer simply whether it publishes useful content. It is whether that content is credible, well-structured, connected and easy for both humans and machines to find and reuse. The bar is rising faster than many organisations realise and the response cannot be another cycle of periodic content refreshes. Meeting it will require a more deliberate, AI-ready operating model; one that treats content as a durable asset to be structured, connected and continuously optimised rather than produced based on a calendar.
Read the article in full here.